Franck Danel

1.5k total citations
17 papers, 1.0k citations indexed

About

Franck Danel is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Franck Danel has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 7 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Franck Danel's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical and Antibiotic Environmental Impacts (4 papers). Franck Danel is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical and Antibiotic Environmental Impacts (4 papers). Franck Danel collaborates with scholars based in Switzerland, United Kingdom and Türkiye. Franck Danel's co-authors include David M. Livermore, Deniz Gür, Lucinda M. C. Hall, Malcolm G. P. Page, N.C.J. Strynadka, Liza de Castro, Mark Paetzel, Heidi A. Lane, A.E. Prota and Jens Pohlmann and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Franck Danel

17 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franck Danel Switzerland 14 591 490 265 227 189 17 1.0k
Beth A. Rasmussen United States 17 511 0.9× 512 1.0× 249 0.9× 234 1.0× 105 0.6× 22 1.1k
M. Galleni Belgium 12 737 1.2× 403 0.8× 240 0.9× 121 0.5× 176 0.9× 15 1.1k
Denis M. Daigle Canada 19 614 1.0× 695 1.4× 273 1.0× 112 0.5× 93 0.5× 28 1.3k
Michiyoshi Nukaga Japan 18 893 1.5× 398 0.8× 407 1.5× 95 0.4× 207 1.1× 38 1.2k
R.A. Powers United States 19 854 1.4× 395 0.8× 461 1.7× 128 0.6× 177 0.9× 33 1.1k
Thomas F. Durand-Réville United States 16 795 1.3× 252 0.5× 445 1.7× 190 0.8× 140 0.7× 20 1.1k
Ronald E. Painter United States 14 566 1.0× 275 0.6× 347 1.3× 133 0.6× 175 0.9× 14 970
Raymond T. Testa United States 15 453 0.8× 242 0.5× 432 1.6× 137 0.6× 70 0.4× 25 801
Xavier Raquet Belgium 17 616 1.0× 458 0.9× 239 0.9× 56 0.2× 144 0.8× 19 936
Dustin T. King Canada 19 952 1.6× 777 1.6× 454 1.7× 296 1.3× 103 0.5× 32 1.7k

Countries citing papers authored by Franck Danel

Since Specialization
Citations

This map shows the geographic impact of Franck Danel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Danel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Danel more than expected).

Fields of papers citing papers by Franck Danel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Danel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Danel. The network helps show where Franck Danel may publish in the future.

Co-authorship network of co-authors of Franck Danel

This figure shows the co-authorship network connecting the top 25 collaborators of Franck Danel. A scholar is included among the top collaborators of Franck Danel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck Danel. Franck Danel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Prota, A.E., Franck Danel, Felix Bachmann, et al.. (2014). The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization. Journal of Molecular Biology. 426(8). 1848–1860. 240 indexed citations
2.
Lovering, Andrew L., Michael Gretes, Franck Danel, et al.. (2012). Structural Insights into the Anti-methicillin-resistant Staphylococcus aureus (MRSA) Activity of Ceftobiprole. Journal of Biological Chemistry. 287(38). 32096–32102. 92 indexed citations
3.
Danel, Franck, Patrick Caspers, Claude Nuoffer, et al.. (2011). Asparaginyl-tRNA Synthetase Pre-Transfer Editing Assay. Current Drug Discovery Technologies. 8(1). 66–75. 14 indexed citations
4.
Bachmann, Felix, Franck Danel, Ruben Martinez, et al.. (2011). Abstract 743: Development of tumor models resistant to the novel microtubule destabilizer BAL27862 (active moiety of the prodrug BAL101553). Cancer Research. 71(8_Supplement). 743–743. 1 indexed citations
5.
Pohlmann, Jens, Laurenz Kellenberger, Stuart Shapiro, et al.. (2010). Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA β-lactams. Bioorganic & Medicinal Chemistry Letters. 20(15). 4635–4638. 4 indexed citations
6.
Sukuru, Sai Chetan K., Thibaut Crépin, Jonathan B. Hill, et al.. (2006). Discovering New Classes of Brugia malayi Asparaginyl-tRNA Synthetase Inhibitors and Relating Specificity to Conformational Change. Journal of Computer-Aided Molecular Design. 20(3). 159–178. 38 indexed citations
7.
Danel, Franck, et al.. (2001). Evidence of dimerisation among class D β-lactamases: kinetics of OXA-14 β-lactamase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1546(1). 132–142. 23 indexed citations
8.
Danel, Franck, Mark Paetzel, N.C.J. Strynadka, & Malcolm G. P. Page. (2001). Effect of Divalent Metal Cations on the Dimerization of OXA-10 and -14 Class D β-Lactamases from Pseudomonas aeruginosa. Biochemistry. 40(31). 9412–9420. 31 indexed citations
9.
Strynadka, N.C.J., Mark Paetzel, Franck Danel, et al.. (2000). Crystal structure of the class D beta-lactamase OXA-10.. Nature Structural Biology. 7(10). 918–925. 134 indexed citations
10.
Danel, Franck, et al.. (1999). OXA-17, a Further Extended-Spectrum Variant of OXA-10 β-Lactamase, Isolated from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 43(6). 1362–1366. 77 indexed citations
11.
Hennig, Michael, Glenn E. Dale, A. D’Arcy, et al.. (1999). The structure and function of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Haemophilus influenzae 1 1Edited by R. Huber. Journal of Molecular Biology. 287(2). 211–219. 51 indexed citations
12.
Danel, Franck. (1999). Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 43(3). 339–344. 31 indexed citations
13.
Danel, Franck, et al.. (1998). Unusual tazobactam-sensitive AmpC beta-lactamase from two Escherichia coli isolates. Journal of Antimicrobial Chemotherapy. 41(1). 115–118. 10 indexed citations
14.
Danel, Franck, Lucinda M. C. Hall, Deniz Gür, & David M. Livermore. (1998). OXA-16, a Further Extended-Spectrum Variant of OXA-10 β-Lactamase, from Two Pseudomonas aeruginosa Isolates. Antimicrobial Agents and Chemotherapy. 42(12). 3117–3122. 59 indexed citations
15.
Danel, Franck, Linda M. Hall, Deniz Gür, & David M. Livermore. (1997). OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain. Antimicrobial Agents and Chemotherapy. 41(4). 785–790. 71 indexed citations
16.
Danel, Franck, Lucinda M. C. Hall, Deniz Gür, Halis Akalın, & David M. Livermore. (1995). Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 35(2). 281–294. 68 indexed citations
17.
Danel, Franck, Lucinda M. C. Hall, Deniz Gür, & David M. Livermore. (1995). OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 39(8). 1881–1884. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth A. Rasmussen Breakdown of academic impact, for papers by M. Galleni Breakdown of academic impact, for papers by Denis M. Daigle Breakdown of academic impact, for papers by Michiyoshi Nukaga Breakdown of academic impact, for papers by R.A. Powers Breakdown of academic impact, for papers by Thomas F. Durand-Réville Breakdown of academic impact, for papers by Ronald E. Painter Breakdown of academic impact, for papers by Raymond T. Testa Breakdown of academic impact, for papers by Xavier Raquet Breakdown of academic impact, for papers by Dustin T. King
Rankless by CCL
2026